FOLH1 and posterior cortical atrophy: Several PSMA PET tracers have been developed and used in clinical PCa diagnosis, such as [68Ga]Ga-PSMA-11 [11,12] and 18F-DCFPyL [13,14], which have already been approved by the FDA.